YTEN - Yield10 Bioscience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.0600
+0.0200 (+1.92%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close1.0400
Open1.0500
Bid0.94 x 900
Ask1.64 x 800
Day's Range1.0200 - 1.1032
52 Week Range0.6800 - 3.1000
Volume21,681
Avg. Volume70,340
Market Cap10.627M
Beta (3Y Monthly)0.83
PE Ratio (TTM)N/A
EPS (TTM)-1.34
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • GlobeNewswire26 days ago

    Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, announced today that it has initiated an early development program in corn to evaluate novel seed yield and drought tolerance traits. Corn is the highest value commercial row crop grown in the United States. Under this program, novel traits discovered by Yield10 will be deployed in corn by a third-party agriculture company with proven expertise introducing new traits into corn.

  • GlobeNewswirelast month

    Yield10 Bioscience Reports Encouraging Results from 2018 Field Tests of C3003 and Announces Advancement of C3003 into Commercial Development for Canola

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today announced encouraging results from the Company’s 2018 Field Tests of C3003, a novel yield trait, in canola, Camelina and soybean. Yield10 is targeting step-changes of 10-20% in the evaluation and development of novel traits to increase seed yield in commercially important crops.  In summary, the C3003 trait produced seed yield increases of up to 11% in the best lines of canola tested. Based on these results, the Company will progress C3003 in canola into the commercial development phase in 2019.

  • GlobeNewswire2 months ago

    Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today named Sherri M. Brown, Ph.D., as a special commercial and technical advisor to the Company, effective immediately. Dr. Brown is currently managing director of The Yield Lab, a global agrifood tech accelerator based in St. Louis.

  • What does Yield10 Bioscience Inc’s (NASDAQ:YTEN) Balance Sheet Tell Us About Its Future?
    Simply Wall St.3 months ago

    What does Yield10 Bioscience Inc’s (NASDAQ:YTEN) Balance Sheet Tell Us About Its Future?

    Zero-debt allows substantial financial flexibility, especially for small-cap companies like Yield10 Bioscience Inc (NASDAQ:YTEN), as the company does not have to adhere to strict debt covenants. However, it also faces Read More...

  • Yield10 Bioscience Inc (NASDAQ:YTEN): When Will It Breakeven?
    Simply Wall St.5 months ago

    Yield10 Bioscience Inc (NASDAQ:YTEN): When Will It Breakeven?

    Yield10 Bioscience Inc’s (NASDAQ:YTEN): Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The US$12.9m market-cap company’sRead More...

  • ACCESSWIRE6 months ago

    Yield10 Bioscience, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 4:30 PM Eastern ...

  • ACCESSWIRE8 months ago

    Venator Materials and Three Additional Specialty Chemicals Stocks on Our Research Desk’s Radar

    LONDON, UK / ACCESSWIRE / July 2, 2018 / If you want a free Stock Review on VNTR sign up now at www.wallstequities.com/registration. This Monday, WallStEquities.com has initiated reports coverage on the following Specialty Chemicals equities: Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN).

  • ACCESSWIRE9 months ago

    Yield10 Bioscience to Present at the 8th annual LD Micro Invitational

    WOBURN, MA / ACCESSWIRE / May 29, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN), a company focused on developing new technologies to achieve step-change improvements to crop yield to enhance global food ...

  • Simply Wall St.9 months ago

    Yield10 Bioscience Inc (NASDAQ:YTEN): Does The Earnings Decline Make It An Underperformer?

    Assessing Yield10 Bioscience Inc’s (NASDAQ:YTEN) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...

  • ACCESSWIRE9 months ago

    Free Pre-Market Technical Pulse on W.R. Grace and Three More Specialty Chemicals Stocks

    Today, WallStEquities.com takes a look at the recent performance of Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN). Stockton-On-Tees, the UK headquartered Venator Materials PLC's stock finished Thursday's session 0.27% lower at $18.37 with a total trading volume of 280,037 shares.